A study in Nature Microbiology shows gut bacteria can hinder Parkinson's drugs. COMT inhibitors may boost microbes that break ...
Explore 2026 CLL frontline choices, from all-oral acalabrutinib–venetoclax to MRD-guided care, plus pipeline advances and ...
As clinicians celebrated results of the PALOMA-2 study at ASCO Annual Meeting in 2016, Gabe S. Sonke, MD, PhD, had a question ...
Across the UK, one in four adults experiences acid reflux, with numerous people encountering it at various points in their lives, especially after consuming large meals. People who suffer from it ...
COMT inhibitors, meant to boost Parkinson’s treatment, unintentionally promote gut bacteria that break down levodopa. This ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
The addition of the AKT inhibitor capivasertib (Truqap) to abiraterone (Zytiga) and androgen deprivation therapy (ADT) ...
AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...
Two BET proteins play distinct roles in gene activation, explaining why BET-targeting therapies have limited responses and pointing toward a more precise mode of therapy.
Lindsey DeSoto, RD, is a nutrition writer, medical reviewer, and registered dietitian who helps clients improve their diet for health-related reasons. Her writing covers a variety of topics, including ...
Levodopa—the gold-standard treatment for Parkinson's disease—increases dopamine in the brain. But as the disease progresses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results